GlassScriptPhysician profile
Shaun Syphus
NPI 1437898541
$2,458.16
in general payments reported to CMS, 2019-2025
20 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $207 · 2024: $965 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.18 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $376.11 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Ucb, INC. | $348.70 | 2023-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $323.53 | 2023-2025 | |
| Leo Pharma INC. | $268.89 | 2023-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $260.13 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Galderma Laboratories, L.P. | $142.17 | 2024-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $115.95 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $115.09 | 2023-2025 | Zoryve |
| Biofrontera INC. | $112.07 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Genzyme Corporation | $58.65 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $54.30 | 2024-2025 | Libtayo, Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.41 | 2024-2025 | Cabtreo |
| Pfizer INC. | $48.77 | 2024 | |
| Sun Pharmaceutical Industries INC. | $48.04 | 2025 | |
| Journey Medical Corporation | $38.61 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $28.99 | 2025 | Bio-Connekt |
| Almirall LLC | $19.80 | 2025 | Seysara |
| Amgen INC. | $19.20 | 2024 | Otezla |
| Botanix Sb INC | $15.46 | 2025 | Sofdra |
| Organon LLC | $14.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Syphus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.